ViiV Healthcare has teamed up with the UN-backed Medicines Patent Pool and three generic manufacturers to expand access to ...

The long-underserved systemic lupus erythematosus (SLE) market is suddenly buzzing with treatment possibilities. Less than ...

In a first, Merck has secured a full approval for Keytruda in a tumor agnostic setting — as a treatment for any unresectable ...

Catalent will be manufacturing a low-cost version of the opioid overdose treatment naloxone as part of a contract with Harm ...

South African-based vaccine manufacturer Aspen Pharmacare was facing reports that it had not received a single order for its ...

Shares of the Swe­den-based rare dis­ease biotech Egetis Ther­a­peu­tics sky­rock­et­ed on Thurs­day af­ter­noon as the ...

Congress is honing in on how it wants to overhaul the rules of the road for pharmacy benefit managers, with a Senate Finance ...

Over the past several years, people living with HIV have been more often telling Theratechnologies that they wanted more ...

Otonomy may be shutting down, but the lessons learned there will live on at another biotech working on new treatments for ...

Belgian biotech Confo Therapeutics has landed $183 million, plus potential royalties, in a drug-discovery deal with Daiichi ...

GSK is dishing out $90 million cash to add an antifungal drug to its commercial portfolio, in a deal spotlighting the pharma ...

Microcap biotech Seelos Therapeutics is halting enrollment of its study in spinocerebellar ataxia type 3 (also known as ...